Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$0.1482 -3.39%
Market Cap
$13.5M
Price Target
Refer to Report
Volume
49.1M
52wk Range
$0.112 - $1.74
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.